Hims & Hers Health, Inc. (HIMS)
Hims & Hers is a telehealth company that connects consumers with licensed providers for prescriptions and health products. It last closed at $17.55 on Nov 17, down 5.44% on the day. HIMS last reported earnings on Mon, Nov 9, 2026. The average 12-month price target from 7 analysts is $29.57 (+68.5% from the last close), with a high of $35.00 and a low of $24.00. Analyst consensus is Hold, based on the latest ratings from 7 firms (2 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in HIMS, 43% of them bullish and 57% bearish. In the past 30 days there were 3 dark pool prints totaling $3.1M, the largest $1.2M.
Key Stats
Last 12 monthsNot reported for this period.
From HIMS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 7 analysts who set a price target on HIMS in the past 90 days. The average target is $29.57, with a high of $35.00 and a low of $24.00, compared with the last close of $17.55.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 10 | Jefferies | Maintained | Hold | $24 |
| Nov 10 | Morgan Stanley | Target lowered | Hold | $28 → $25 |
| Nov 10 | Evercore ISI Group | Maintained | Hold | $27 |
| Nov 10 | Needham | Target lowered | Buy | $42 → $32 |
| Sep 11 | JP Morgan | Assumed coverage | Hold | $35 → $32 |
Technical Analysis
The stock is 41% below its 20 day and 55% below its 50 day average. It is 52% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 30), oversold. The nearest support is the Pivot S1 at $16.89, and the nearest resistance the Pivot at $17.80.
| RSI (14) | 29.54 | Oversold below 30 | Oversold |
| MACD | -2.67 | Below its signal line | Bearish |
| Stochastic | 5.3 | Near the bottom of its range | Oversold |
| ADX (14) | 28.0 | Trending down | |
| Williams %R | -96.8 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -137.5 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −31.7% | Change over 10 sessions | Bearish |
| ATR (14) | $2.04 | Typical daily range, 11.6% of price |
| RSI (14) | 33.66 | Weak, oversold below 30 | Neutral |
| MACD | -1.86 | Below its signal line | Bearish |
| Stochastic | 12.5 | Near the bottom of its range | Oversold |
| ADX (14) | 16.1 | No clear trend | |
| Williams %R | -97.6 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -287.8 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −36.2% | Change over 10 sessions | Bearish |
| ATR (14) | $4.66 | Typical daily range, 26.5% of price |
What happened before
See how HIMS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How HIMS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
Whale Options Flow
90DNo whale options trades in HIMS in the last 90 days.
Dark Pool
30DHIMS Institutional Ownership
Full report →- ●227 buying vs 250 selling
- ●Shares held by funds +0.2%
- ▼Funds holding -37
- ▲Superinvestors: 2 added, 1 cut
- ▲Put/call 0.95 to 0.69
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 475 | 512 | −7.2% |
| In funds' top 10 | 8 | 9 | −11.1% |
| Held by funds | – | – | – |
| New / increased | 62 / 165 | 141 / 179 | −29.1% |
| Reduced / sold out | 163 / 87 | 129 / 66 | +28.2% |
| Put/call ratio | 0.69 | 0.95 | −27.5% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HIMS is in one of them and how their past HIMS trades turned out.
HIMS News Tone and Price
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered HIMS in an article yet. Here's the latest on the wider market.
HIMS Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Tony WiedR · WI | Sell | $100K – $250K | Dec 17, 2025 | Jan 9, 2026 | 23 d |
| Lisa McClainR · MI | Buy | $1K – $15K | Aug 4, 2025 | Sep 12, 2025 | 39 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Hims & Hers Health
Hims & Hers is a telehealth company based in San Francisco, California. It connects patients with licensed healthcare professionals who can prescribe medications for conditions such as hair loss, sexual health, weight loss, dermatology and mental health, with prescriptions filled through pharmacies it operates and other licensed pharmacies. The company also sells nonprescription health, wellness, skincare and supplement products, along with laboratory testing, many on a subscription basis. Its customers are consumers in the United States, Canada, the United Kingdom and parts of Europe.
- Headquarters
- San Francisco, CA
- Founded
- 2017
- Website
- forhims.com ↗




